127 related articles for article (PubMed ID: 14526122)
1. Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.
Maldonado-Rodríguez R; Espinosa-Lara M; Barrera-León O; Colin-Tovar C; González-Yebra B; Salcedo-Vargas M; Santiago-Hernández JC; Méndez-Tenorio A; Beattie KL
Mol Biotechnol; 2003 Oct; 25(2):113-29. PubMed ID: 14526122
[TBL] [Abstract][Full Text] [Related]
2. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
[TBL] [Abstract][Full Text] [Related]
3. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
Jindrichova S; Kodet R; Krskova L; Vlcek P; Bendlova B
J Mol Med (Berl); 2003 Dec; 81(12):819-23. PubMed ID: 14618242
[TBL] [Abstract][Full Text] [Related]
4. Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Bugalho MJ; Coelho I; Sobrinho LG
Eur J Endocrinol; 2000 Jun; 142(6):573-5. PubMed ID: 10822219
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.
Elisei R; Cosci B; Romei C; Agate L; Piampiani P; Miccoli P; Berti P; Basolo F; Ugolini C; Ciampi R; Nikiforov Y; Pinchera A
J Clin Endocrinol Metab; 2004 Nov; 89(11):5823-7. PubMed ID: 15531548
[TBL] [Abstract][Full Text] [Related]
6. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
[TBL] [Abstract][Full Text] [Related]
8. Hybridization of glass-tethered oligonucleotide probes to target strands preannealed with labeled auxiliary oligonucleotides.
Maldonado-Rodriguez R; Espinosa-Lara M; Calixto-Suárez A; Beattie WG; Beattie KL
Mol Biotechnol; 1999 Feb; 11(1):1-12. PubMed ID: 10367278
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
11. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
Musholt PB; Musholt TJ; Moley JF; Scheumann GF
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
[TBL] [Abstract][Full Text] [Related]
12. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
13. The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma?
De Miguel M; Fernández-Santos JM; Trigo-Sánchez I; Matera I; Ceccherini I; Martín I; Romeo G; Galera-Davidson H
Lab Anim; 2003 Jul; 37(3):215-21. PubMed ID: 12869284
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
15. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.
Vandenbosch K; Renard M; Uyttebroeck A; Sciot R; Matthijs G; Legius E
Genet Couns; 2005; 16(1):95-100. PubMed ID: 15844786
[TBL] [Abstract][Full Text] [Related]
17. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations.
Liu W; Smith DI; Rechtzigel KJ; Thibodeau SN; James CD
Nucleic Acids Res; 1998 Mar; 26(6):1396-400. PubMed ID: 9490783
[TBL] [Abstract][Full Text] [Related]
18. LightCycler PCR assay for genotyping codon 634 mutations in the RET protooncogene.
de la Fuente M; Quinteiro C; Dominguez F; Loidi L
Clin Chem; 2001 Jun; 47(6):1131-2. PubMed ID: 11375311
[No Abstract] [Full Text] [Related]
19. Mutation detection by stacking hybridization on genosensor arrays.
Maldonado-Rodriguez R; Espinosa-Lara M; Loyola-Abitia P; Beattie WG; Beattie KL
Mol Biotechnol; 1999 Feb; 11(1):13-25. PubMed ID: 10367279
[TBL] [Abstract][Full Text] [Related]
20. RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis.
Margraf RL; Mao R; Highsmith WE; Holtegaard LM; Wittwer CT
J Mol Diagn; 2007 Apr; 9(2):184-96. PubMed ID: 17384210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
